Novavax vaccine delays slump stock, Abbott Labs raises guidance, Biogen beats Q3 estimates

Yahoo Finance's Brian Sozzi, Brian Cheung and Julie Hyman break down how Novavax, Biogen, and Abbott Labs are faring in Wednesday’s market